Hepcinat LP

Hepcinat LP is an antiviral combination medication containing Ledipasvir and Sofosbuvir used to treat chronic Hepatitis C virus (HCV) infection. It functions by inhibiting viral replication, thereby lowering the amount of the virus in the body and clearing it from the blood over a 12 to 24-week treatment period.